Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room - Disposals of own shares

INFORMATION REGLEMENTEE


[21/08/2020 | 20:02]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6elZaTLAIWYK8rGp7ramZNHXB3LDMIkCuDjmcZ61V4Vx8XKitqlSbNn7=
C-2Bq8FuaA4wqLwYfZutFdZrtMRUDLj5Exq9k9_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7=
KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1=
wavOZ-2Br9Ts8l3upAP5SW-2B9bZnBO5PwEzzxgLSIPpnGbM9LaSA0VOsf51p6YOfEwrB1kN1Op=
xgFGcuMMin-2BJv1yj8-2FgFq7Mbmt3s5zYfsGQcoDnKNOVpvA6rGieZjgkPJAf7p-2BSfKr-2F=
rkiH2V3Ga18tYZHsJu-2FdyNkEb7sdeKdYfPuS9xNCLzs7V0xL3QnlEidRUlKOs0Ce3tPsn6Pl6=
Ckh0dQBVnDlFwn93FMf4FxbkfW3TdWvVqCBBVM1Ny3xQEik-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 21 August 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regulat=
ed information

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB=C2=A0SA/NV (=E2=80=9CUCB=E2=80=9D or =
the =E2=80=9CCompany) (Euronext Brussels: UCB)=C2=A0announces that, followi=
ng exercises of stock options by members of its personnel, it has disposed =
of UCB shares OTC in view of deliveries of these shares to the relevant mem=
bers of the personnel, within the framework of the Long Term Incentive Prog=
ram of the UCB Group, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6elZaTLAIWYK8rGp7ramZNHXzUJAFMyrQQls-2F5j0fFXa4NVmdEFs-2=
FaECIsmb80kNxfYSJIx6BxymBFQQ69e7o7OORDPB_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wavOZ-2Br9Ts8l3upAP5SW-2B9bZnBO5PwEzzxgLSIPpnGbM9LaSA0VOsf51p6YOfEwrB1kN1=
OpxgFGcuMMin-2BJv1yj8-2FgFq7Mbmt3s5zYfsGQcoMq7kytEvLwmRbJQmdEowjMOpvngvxiY2=
I-2FOY77JWivFgjRiPeZjmgHWijvAy7I7QB8H02EPmX4gNXcXBI-2BGiVJvSfzQyycCF-2Bk-2B=
n-2F4I6dnfBT4OVcdnSnunXukCvhIDCG8PFpkQT36nKRTXNbhHaHE-3D

This press release is available on UCB=C2=A0SA/NV=E2=80=99s website via the=
following link (https://u7061146.ct.sendgrid.net/ls/click?upn=3DTeZUXWpUv-=
2B6TCY38pVLo9lhRUe6Ma4TusKdX-2BpaIUCNBSVwJAbLzK20LottA-2BzL-2Bt1fiX5ld0cK7J=
fIQFYDVTg-3D-3D8uK5_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86b=
Sl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wavOZ-2Br9Ts8l3upAP=
5SW-2B9bZnBO5PwEzzxgLSIPpnGbM9LaSA0VOsf51p6YOfEwrB1kN1OpxgFGcuMMin-2BJv1yj8=
-2FgFq7Mbmt3s5zYfsGQcoOJxckkSoaWLUshlDu6W66h9FrIxmYxBioFKgO2QBTdVUub54rS9XV=
xNDrGPfGSIIzh8pvRm4npPK6GTGiqJro5a3kDWgyCzPvmEkcw-2FHunyl2fi-2B2CJUlkwEb5oo=
JJlPZwAd2KdOQfx940Lrr6TZYo-3D .=C2=A0

Investor relations=C2=A0

Antje Witte,
Investor Relations, UCB
T +32 2 559 94 14
antje.witte@ucb.com

Isabelle Ghellynck,
Investor Relations, UCB
T +32 2 559 95 88
isabelle.ghellycnk@ucb.ce
=C2=A0
About UCB

UCB, Brussels, Belgium (www.ucb.com (https://u7061146.ct.sendgrid.net/ls/cl=
ick?upn=3DTeZUXWpUv-2B6TCY38pVLo9rKKs1SKiGimp-2BflGZwlYo0-3Dxtjj_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1wavOZ-2Br9Ts8l3upAP5SW-2B9bZnBO5PwEzzxgLSIPpnGbM9=
LaSA0VOsf51p6YOfEwrB1kN1OpxgFGcuMMin-2BJv1yj8-2FgFq7Mbmt3s5zYfsGQcoON63rLv3=
yFqaASgz5KZwfIxn0asNf6ODAO90LagotXfgyOHLysbzLe0LDoCIE0hkpKA0f1pGJx5GhaCBshK=
OZKK2SWa9BiK4Lo-2Fqrn9cnMjLh2TYK40KRh8JKqYM11iQvT304xIPw40uqnMo5LQtLU-3D ) =
is a global biopharmaceutical company focused on the discovery and developm=
ent of innovative medicines and solutions to transform the lives of people =
living with severe diseases of the immune system or of the central nervous =
system. With 7 500 people in approximately 40 countries, the company genera=
ted revenue of =E2=82=AC 4.9 billion in 2019. UCB is listed on Euronext Bru=
ssels (symbol: UCB). Follow us on Twitter: @UCB_news

Image
Disposals of own shares August 21 2020 (https://u7061146.ct.sendgrid.net/ls=
/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6elZaTLAIWYK8rGp=
7ramZNHXzUJAFMyrQQls-2F5j0fFXa4Lx0GY0xrBbruY9NeAtySSY-3DZsc__xDPID0vOuylFAU=
8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FO=
eoCOG9ekocVj-2F2X9c9g1wavOZ-2Br9Ts8l3upAP5SW-2B9bZnBO5PwEzzxgLSIPpnGbM9LaSA=
0VOsf51p6YOfEwrB1kN1OpxgFGcuMMin-2BJv1yj8-2FgFq7Mbmt3s5zYfsGQcoAS43Us2lQT7A=
HyddpjGRuNJ5Alv10eNrTpmXv4yddnOkQhoc5pF5e8VFFAZjqk95rkFxGKrq4xNYPQbwLTefnLR=
G4nYGB3ImD6GKfLUbTkVat5cdpai0gQpZem-2BbVjli2yEdz8vzg7E9kgsSNl6H18-3D Generi=
cFile
200821 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6elZaTLAIWYK8r=
Gp7ramZNHXzhSwOl7hqnrPiCyzK7dhmBps-2FeGyYVHGqGcIS6PI61w-3DGesQ_xDPID0vOuylF=
AU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2=
FOeoCOG9ekocVj-2F2X9c9g1wavOZ-2Br9Ts8l3upAP5SW-2B9bZnBO5PwEzzxgLSIPpnGbM9La=
SA0VOsf51p6YOfEwrB1kN1OpxgFGcuMMin-2BJv1yj8-2FgFq7Mbmt3s5zYfsGQcoLWBAzgsgXA=
-2F-2BE-2F6CXvpGGIBiKm8y9bkQouOi9-2BCa-2FIR71SwEYBaPeOjDXTpKrTOjo3-2FbkgDDr=
f1AYwz-2BMsTqNNKWPclLnI0y9P9cxf9Tr8hStDlAneWSqe35qiE70owiav27l9nUj685wcqDBu=
suq4-3D GenericFile
200821 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6elZaTLAIWYK8rGp7ramZN=
HXmp65pMA4VnuoOQyXGg4gZGiPqIcmcnVTWlMkuF8tZEI-3DQZnJ_xDPID0vOuylFAU8fv4e60w=
ei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ek=
ocVj-2F2X9c9g1wavOZ-2Br9Ts8l3upAP5SW-2B9bZnBO5PwEzzxgLSIPpnGbM9LaSA0VOsf51p=
6YOfEwrB1kN1OpxgFGcuMMin-2BJv1yj8-2FgFq7Mbmt3s5zYfsGQcoDGCrXeaLFNN-2Fe7qiCs=
BhHRj7ladvSScT6v0Fy2kBbXGtTFq7i6HfFvPCN79VMAfUBTjNPzGI-2BL4MDJlueJMXOuB-2F8=
AF91g-2BUAahsk-2FaGpqJZiaekHyo9AaeEbU5igfgJWMe1p1NO2fm-2B-2FUVpmeJFX4-3D Ge=
nericFile
200821 - Alie nation d actions propres (https://u7061146.ct.sendgrid.net/ls=
/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6elZaTLAIWYK8rGp=
7ramZNHXrJLqX9N21sYK03CVozbDeGep3B0FkrixdtVfY36oDg4-3DGlET_xDPID0vOuylFAU8f=
v4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeo=
COG9ekocVj-2F2X9c9g1wavOZ-2Br9Ts8l3upAP5SW-2B9bZnBO5PwEzzxgLSIPpnGbM9LaSA0V=
Osf51p6YOfEwrB1kN1OpxgFGcuMMin-2BJv1yj8-2FgFq7Mbmt3s5zYfsGQcoEJq-2F4-2BmwRS=
u3eLH-2FAYfjDJKBDQC7xZ9Fy0RXQPIA2DXNDg0sy2dbx-2BAVDTwD3eNkAbv-2FfJqcLwMyiSE=
iC10uwMsyETD5CLgdLQXQMMczKh-2FEpiDkcGbRSNcWFOy5z7lhMLhXPo0lqKUbHZ6YyJOTog-3=
D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXGH-2F3sgPS-2FooXpsDXxH-2By-2BsQ=
R4W3QQbwfcqSWblGpbGen8hkpo3ZKpp2eUsBUooBuG6JZIQyH0A4FV1kZVvxlVJVKvMbK6Pj-2B=
WqSNV9kprT4-3DeEQ3_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wavOZ-2Br9Ts8l3upAP5=
SW-2B9bZnBO5PwEzzxgLSIPpnGbM9LaSA0VOsf51p6YOfEwrB1kN1OpxgFGcuMMin-2BJv1yj8-=
2FgFq7Mbmt3s5zYfsGQcoI3Dfw9P0iqnK-2Brsir6u-2BAL4OWIT9X-2FEawGEQbZZLV9-2FGxA=
VPJC-2F-2B6ulOP15GfEb0wLiJOSjzS5zCrxuAP8gW3rHmxzdeuLQRSWI84S12Aruq0lDY3T6BV=
8PJz85Ygg5pm5nRnnCCNQZprYcFq4z7zY-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=